Dermatological Changes in Oncology Patients – Adults and Children

    Dolores Gonzalez Fabra, Ana Paula Kayo, Andrea Regina de Oliveira Leal … Flávia Guglielmino
    Studysummary This study created a novel classification for dermatological and cosmiatric changes caused by cancer treatments, categorizing them as triggered, exacerbated, or unrelated to the treatment.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on portalnepas.org.br →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Malignancy and Cancer Treatment-Related Hair and Nail Changes Dermatologic Clinics · 2007
    2. Atrophic Telogen Effluvium from Cytotoxic Drugs and a Randomized Controlled Trial to Investigate the Possible Protective Effect of Pretreatment with a Topical Vitamin D3 Analogue in Humans British Journal of Dermatology · 2005
    3. A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma Dermatology · 2004
    4. Cutaneous Toxicities of Cancer Therapy Current opinion in oncology/Current opinion in oncology, with cancerlit · 2002
    5. Cutaneous Reactions to Chemotherapeutic Agents ˜The œAmerican journal of the medical sciences · 2001